Medicare Enrolled
Dr. Daniel Connell, MD
Gastroenterology · Lancaster, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Connell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Connell?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Connell
Dr. Daniel Connell is a gastroenterology specialist in Lancaster, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Connell performed 6,337 Medicare services across 651 unique beneficiaries.
Between the years covered by Open Payments, Dr. Connell received a total of $5,195 from 35 pharmaceutical and/or device companies across 264 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Connell is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in PA
$5,195 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,337
Medicare services
Top 3% in PA for gastroenterology
651
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~334 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
4,800 | $17 | $49 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
840 | $26 | $115 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
120 | $62 | $186 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
89 | $201 | $1,025 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
59 | $82 | $270 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
59 | $38 | $85 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
44 | $61 | $120 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
39 | $166 | $750 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
35 | $173 | $750 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
33 | $69 | $530 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
31 | $64 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
31 | $97 | $240 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
30 | $65 | $270 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
29 | $123 | $875 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $40 | $120 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
16 | $49 | $216 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
16 | $100 | $301 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
16 | $22 | $101 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
13 | $86 | $645 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
13 | $56 | $207 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
89.5% high complexity
2.8% medium
7.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,195
Total received (2018-2024)
Avg $742/year across 7 years
Top 30% in PA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
264
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,195 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,362
2023
$969
2022
$1,047
2021
$260
2020
$370
2019
$682
2018
$506
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$353
PFIZER INC.
$213
Mallinckrodt Hospital Products Inc.
$122
Takeda Pharmaceuticals U.S.A., Inc.
$74
Janssen Biotech, Inc.
$71
Madrigal Pharmaceuticals
$70
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$68
Celgene Corporation
$61
Ipsen Biopharmaceuticals, Inc
$58
IRONWOOD PHARMACEUTICALS, INC
$51
Phathom Pharmaceuticals, Inc.
$48
Regeneron Healthcare Solutions, Inc.
$34
Intercept Pharmaceuticals, Inc.
$28
GENZYME CORPORATION
$28
Lilly USA, LLC
$23
Ferring Pharmaceuticals Inc.
$20
Ardelyx, Inc.
$20
Sandoz Inc.
$18
Top 3 companies account for 50.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$894
AbbVie Inc.
$782
Celgene Corporation
$429
Takeda Pharmaceuticals U.S.A., Inc.
$425
AbbVie, Inc.
$414
PFIZER INC.
$350
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$226
Janssen Biotech, Inc.
$213
Intercept Pharmaceuticals, Inc.
$163
Covidien LP
$122
Mallinckrodt Hospital Products Inc.
$122
GENZYME CORPORATION
$102
Regeneron Healthcare Solutions, Inc.
$97
IRONWOOD PHARMACEUTICALS, INC
$94
Merck Sharp & Dohme LLC
$81
Madrigal Pharmaceuticals
$70
Gilead Sciences, Inc.
$63
Ipsen Biopharmaceuticals, Inc
$58
Ferring Pharmaceuticals Inc.
$55
Ironwood Pharmaceuticals, Inc
$51
NESTLE HEALTHCARE NUTRITION INC.
$49
Phathom Pharmaceuticals, Inc.
$48
INTERCEPT PHARMACEUTICALS, INC.
$38
Synergy Pharmaceuticals Inc
$28
Echosens North America, Inc.
$27
Blueprint Medicines Corporation
$26
Merck Sharp & Dohme Corporation
$25
Lilly USA, LLC
$23
Amgen Inc.
$23
Ardelyx, Inc.
$20
Sandoz Inc.
$18
UCB, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$14
Daiichi Sankyo Inc.
$14
Nestle HealthCare Nutrition Inc.
$13
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
AMITIZA · AMJEVITA · Amitiza · Bylvay · CIMZIA · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · Entyvio · Fibroscan · HUMIRA · HYRIMOZ · Humira · IBSRELA · INJECTAFER · IQIRVO · LINZESS · Linzess · MAVYRET · ManoScan · Mavyret · OCALIVA · OMVOH · REBYOTA · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · Smart Pill · TERLIVAZ · TREMFYA · TRULANCE · Trulance · UCERIS · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
95
Per 100K population
17.1
County median income
$83,703
Nearest hospital
PENN STATE HEALTH LANCASTER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Connell is a mixed practice specialist, with above-average Medicare volume (top 3% in PA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Connell experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Connell performed 4,800 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Connell receive payments from pharmaceutical companies?
Yes. Dr. Connell received a total of $5,195 from 35 companies across 264 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Connell's costs compare to other gastroenterologists in Lancaster?
Dr. Connell's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Connell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Lancaster
Browse gastroenterologists in Lancaster ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in PA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in PA
Which PA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology